Short Interest in Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) Grows By 65.3%

Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) was the recipient of a significant increase in short interest in February. As of February 28th, there was short interest totalling 62,800 shares, an increase of 65.3% from the February 13th total of 38,000 shares. Based on an average daily trading volume, of 1,200 shares, the days-to-cover ratio is presently 52.3 days.

Surgical Science Sweden AB (publ) Stock Performance

Surgical Science Sweden AB (publ) stock remained flat at $14.39 during trading on Friday. Surgical Science Sweden AB has a 52 week low of $11.30 and a 52 week high of $15.25. The firm’s 50 day moving average price is $14.56 and its 200 day moving average price is $13.06.

About Surgical Science Sweden AB (publ)

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases.